Home | Community | Message Board


This site includes paid links. Please support our sponsors.


Welcome to the Shroomery Message Board! You are experiencing a small sample of what the site has to offer. Please login or register to post messages and view our exclusive members-only content. You'll gain access to additional forums, file attachments, board customizations, encrypted private messages, and much more!

Shop: Kraken Kratom Kratom Capsules for Sale   MagicBag.co All-In-One Bags That Don't Suck   North Spore Bulk Substrate   Mushroom-Hut Mono Tub Substrate   Left Coast Kratom Buy Kratom Extract   PhytoExtractum Buy Bali Kratom Powder   Unfolding Nature Unfolding Nature: Being in the Implicate Order

Jump to first unread post Pages: 1 | 2 | Next >  [ show all ]
OfflinemotamanM
old hand
 User Gallery
Registered: 12/18/02
Posts: 6,047
Last seen: 7 days, 13 hours
Dennis McKenna
    #3775965 - 02/13/05 08:46 PM (19 years, 1 month ago)

I will be audio interviewing Dr. Dennis McKenna in a few weeks which will be aired on ShroomeRadio.


Any relevant questions that you might have for Dr. McKenna will be considered for material. I am primarily looking for Heffter Research Institute related questions/comments, but all are welcomed.  :smirk:



peace
-motaman

Extras: Filter Print Post Top
InvisibleSilversoul
Rhizome
Male User Gallery

Registered: 01/01/05
Posts: 23,576
Loc: The Barricades
Re: Dennis McKenna [Re: motaman]
    #3776206 - 02/13/05 09:28 PM (19 years, 1 month ago)

Maybe you should post this in the Shroomery Radio forum.


--------------------

Extras: Filter Print Post Top
InvisibleWorld Spirit
PNW
 User Gallery

Folding@home Statistics
Registered: 07/27/01
Posts: 9,817
Re: Dennis McKenna [Re: motaman]
    #3776233 - 02/13/05 09:33 PM (19 years, 1 month ago)

1. Why do you believe psilocybin mushrooms are on the Earth? What purpose do they serve?

2. In what context (setting and reason) can fungi be utilized most effectively?

3. How has fungi effected you personally, overall?

4. Tell us about your brother, Terrence. What was he like from a brother's perspective? What was the most frequent thing you discussed with him when it was just you and him? How has his work and life affected your work and your life?

5. What is the future for Entheogens and Humanity?

Extras: Filter Print Post Top
OfflinemotamanM
old hand
 User Gallery
Registered: 12/18/02
Posts: 6,047
Last seen: 7 days, 13 hours
Re: Dennis McKenna [Re: Silversoul]
    #3776246 - 02/13/05 09:35 PM (19 years, 1 month ago)

Quote:

Paradigm said:
Maybe you should post this in the Shroomery Radio forum.




Not enough traffic there to obtain my desired input..  :smirk:


--------------------
http://heffter.org

Extras: Filter Print Post Top
OfflineRoseM
Devil's Advocate
Female User Gallery

Registered: 09/24/03
Posts: 22,518
Loc: Mod not God Flag
Last seen: 1 year, 7 months
Re: Dennis McKenna [Re: motaman]
    #3776894 - 02/14/05 12:02 AM (19 years, 1 month ago)

1. Dennis, how do we return to a more, "Entheogen friendly" world? What can the Shroomerites, and Shroomery community do to help?

2. Terrance is dead, Leary is dead, who should we look to now? Who is carrying the torch? Who is the guru of Mushrooms (or Entheogens in general)? Who best communicates to this, sound-byte, Internet-Savoy society? Leary's Merry "Prankster-type" approach can sound a bit antique to THIS generation. Frankly, your brother Terrance was too smart for his own good. Who do we point people towards, if they want to learn about The Psychadellic Experience or Shamanism? Who is rellivant today?


--------------------
Fiddlesticks.


Extras: Filter Print Post Top
InvisibleTheHateCamel
Research &Development -DBK
Registered: 01/31/03
Posts: 15,738
Re: Dennis McKenna [Re: motaman]
    #3777466 - 02/14/05 05:37 AM (19 years, 1 month ago)

Shit, don't ask him about his brothers ideas.

Tell him the Shroomery said thank you.

Extras: Filter Print Post Top
OfflineVertigo6911
Entheobotanist
Male User Gallery

Folding@home Statistics
Registered: 12/04/04
Posts: 1,834
Loc: Netherlands
Last seen: 17 years, 4 months
Re: Dennis McKenna [Re: TheHateCamel]
    #3779081 - 02/14/05 03:17 PM (19 years, 1 month ago)

Terrence once called psilocybine "a starship manned by every person who has done it before you".
Maria Sabina at one time got a pot of psilocybine pills
wich were a sythesised version. according to the shamaness
the pills contained the 'spirit' of the mushroom...

id like to hear Dennis's point of view on this.


--------------------
-Know ye not that ye are gods?-
My homepage

Extras: Filter Print Post Top
OfflineMetaShroom
菌类
 User Gallery

Registered: 06/02/02
Posts: 1,462
Loc: East Anglia UK
Last seen: 16 years, 9 months
Re: Dennis McKenna [Re: Vertigo6911]
    #3779680 - 02/14/05 05:15 PM (19 years, 1 month ago)

Apart from self-exploration, do you think the psychedleic experience has anything meaningful to tell us?


--------------------
:sleepingcow:  :penguinmonkey: :blah:

JOIN MAPS -> www.MAPS.ORG

Extras: Filter Print Post Top
InvisibleJohn
ssdp.org

Registered: 08/08/03
Posts: 7,026
Loc: Vancouver, B.C.
Re: Dennis McKenna [Re: MetaShroom]
    #3785640 - 02/15/05 08:21 PM (19 years, 1 month ago)

are bert and ernie really gay?


--------------------
There's a thin line between sanity and insanity... and I just snorted it.

Extras: Filter Print Post Top
Offlinelonebuddha
whats it allabout?
Registered: 11/01/04
Posts: 255
Last seen: 3 years, 9 months
Re: Dennis McKenna [Re: motaman]
    #3786611 - 02/15/05 10:39 PM (19 years, 1 month ago)

Actually what is dennis doing now? Is he even cut out of the same mold as his brother?

Extras: Filter Print Post Top
OfflinemotamanM
old hand
 User Gallery
Registered: 12/18/02
Posts: 6,047
Last seen: 7 days, 13 hours
Re: Dennis McKenna [Re: lonebuddha]
    #3787662 - 02/16/05 01:22 AM (19 years, 1 month ago)

Quote:

lonebuddha said:
Actually what is dennis doing now? Is he even cut out of the same mold as his brother?




Sure he is of the same mold...

http://heffter.org/


Quote:

Overview



We have spent the last few years building the world?s only neuroscience program researching the medical potential of hallucinogens. We now have a world-class program in place, Nobel Prize winning advisors, and wide support among neuroscientists. And remarkably, the first clinical trials with a hallucinogen in human subjects in the United States in 30 years, funded by Heffter, are now underway.

It has taken patience and persistence to bring the team together, and to design the research. All of that is now well in place. Our research is growing like a well-tended garden, but just as lack of nitrogen slows plant growth, funding is now the limiting factor in our efforts.

Our program continues to develop with a steady progress. The Heffter Research Center in Zurich has grown, and there are now 8 people there working on the neuroscience of hallucinogens. Several clinical research programs are maturing in the United States, and the work in Russia continues. Here are some highlights:



Obsessive Compulsive Disorder Study

The first clinical research study with a hallucinogen in the United States in 30 years has begun. We?ve funded a study led by Dr. Francisco Moreno at the University of Arizona Medical School to look into whether psilocybin (which occurs naturally in ?magic mushrooms?) can be efficacious in the treatment of obsessive compulsive disorder (OCD). Several anecdotal reports have suggested that acute use of hallucinogens may lead to a profound reduction of symptoms. OCD is a relatively common condition: many researchers place it among the 4 most common psychiatric afflictions that outpatients seek treatment for in the United States. OCD appears to result from serotonin dysfunction. Current treatment relies on the Prozac-like ?selective serotonin re-uptake inhibitors (SSRI?s).? But these work well only for a relatively small percentage of patients. Psilocybin is a potent serotonin agonist, whose mechanism of action is altogether different from that of the SSRI?s.

Two important questions will be addressed in this study: 1) do potent hallucinogens lead to an acute decrease in the symptoms of OCD?; and 2) if so, is a full hallucinogenic dose required to demonstrate significant reduction in the symptoms of OCD? The study was of course fully approved by the federal government; a pharmaceutical company manufactured the psilocybin.

The first patients have received treatment with psilocybin, and the results appear promising. Our deep hope is that we may find that psilocybin, a non-toxic and naturally occurring substance, provides a breakthrough treatment for this widespread and debilitating condition.



Easing the Anxiety of Death

Early studies in the 1960s and 70s produced profoundly interesting results when hallucinogens were given to patients in their dying process. An overwhelming majority of them gained benefit from the treatment. Anxiety was reduced, and for many, physical pain diminished significantly. These results were a prime reason to start up the Heffter Institute in the first place, because they were the most well documented evidence of therapeutic value for hallucinogens.

According to a report issued in June 2001 by The National Cancer Policy Board of the Institute of Medicine and National Research Council, the medical establishment is fixated on finding a cure for cancer but is largely inattentive to the agony of cancer patients. According to the Board, American society must devote more resources toward helping the approximately 550,000 Americans dying annually of cancer, by focusing on palliative care, which addresses the relief of symptoms.

In other words, we must work actively to relieve the pain and suffering of those with cancer. Our new UCLA end-stage cancer study is precisely designed to do this. We plan to administer psilocybin to end-stage cancer patients, in a carefully controlled setting, to reduce their suffering.
The study leader is Dr. Charles Grob of Harbor-UCLA Medical Center. Dr. Grob was the first researcher to conduct FDA-approved human research with 3,4-methylenedioxy-methamphetamine (MDMA). Dr. Grob?s extensive clinical experience will be particularly valuable for this work, because of the fragile emotional condition that end-stage cancer patients frequently experience.

The study focuses on whether anxiety in the dying can be significantly reduced by the appropriate administration of psilocybin. Any attendant reduction in pain will also be measured. The protocol has been submitted for FDA approval, and we hope to see the clinical phase begin in late 2002 or early 2003.



Swiss Heffter Research Center

Professor Franz Vollenweider at the University of Zurich continues to build an extensive and elegant program of research into the nature of consciousness, using hallucinogens as research tools. The importance of his work was recognized in an award in July 2002 from the British Association of Psychopharmacology. He now has a team of 8 people working with him on a series of co-ordinated studies. Let us look at two, so as to get a taste of his work.

The Swiss team is carrying out a study on the effects of low dose psilocybin on memory in human subjects between 50 and 65 years of age. They should learn about the effects of serotonergic agents in facilitating memory in this population for whom measurable memory deficits are an every day fact of life. This study will also be part of the Swiss team?s long-term project of investigating how memory is used to construct the human sense of self.

Moving to the clinical dimension, the Swiss team has developed a protocol to test the feasibility of using psilocybin in the treatment of anorexia and bulimia. These disorders may have an etiology similar to that of obsessive compulsive disorder. The thought, therefore, is that a serotonin agonist may also prove efficacious in their treatment. The design of this eating disorder study opens up the exciting possibility of running clinical studies in Switzerland in parallel with the powerful basic neuroscience studies that our Swiss colleagues are carrying out so adeptly.



LSD and Gene Expression within the Mammalian Brain

Despite research over the past 30 years, the mechanism of action of hallucinogenic drugs remains largely a mystery. Research has primarily focused on how the drugs affect neurotransmitters. A team of researchers at Vanderbilt University School of Medicine, including Dr. Elaine Sanders-Bush and Dr. Charles Nichols and jointly funded by Heffter and the National Institutes of Health, has now for the first time used state of the art functional genomic and molecular methods to investigate the brain?s genetic response to LSD.

The investigators began with the question whether some behaviors elicited by hallucinogens are the result of temporary changes in gene expression in the brain. They used the powerful technology of DNA microarrays?small glass slides, about thumbnail sized, that have about ten thousand gene sequences printed onto them using actual DNA. Each of these sequences represents a unique gene. The researchers have already screened one chip of 10,000 and are in the process of screening a second chip with another 10,000 genes. Because the predicted size of the number of genes in a human is only 30-40,000, a gene ?chip? may represent nearly one third of the genome.

Results to date show that LSD induces expression changes in a relatively small but important collection of genes. Many of these genes influence the way neurons change physically to alter functional abilities. These genes may thus play a role in learning and the storage of memories. By combining these results with current signal transduction mechanisms, electrophysiology, and behavioral experiments, we may finally begin to grasp the larger picture of how the effects of hallucinogens are produced at the molecular level. This will in turn help us understand the physical substrate of cognition.



Clinical Investigations of the Therapeutic Applications of Ayahuasca in Human Subjects

The recent success of the nutraceutical industry demonstrates that the public is interested in healing through botanical formulations. Yet the healing properties of the most powerful, ancient, and interesting botanicals have not been clinically studied by Western medicine. In a new project led by Dr. Dennis McKenna at the University of Minnesota Medical School, we propose to do all the work needed to make clinical studies with ayahuasca?a potent hallucinogenic traditional plant medicine from the Amazon?possible in this country.
Such studies should lead in time to the recognition and use of ayahuasca within medical practices, in conjunction with appropriate adjunct therapies. The work prior to clinical studies is extensive. It is primarily of two types: formulating a standard extract for research purposes, and gaining all the needed governmental approvals. This will take at least a year of work, well worth the effort to gain the freedom to medically explore the healing powers of this fascinating plant medicine. This project is now in the design phase; if we find the needed funds, much will happen.



Long-term Effects of Peyote Use

Although we believe that hallucinogens have real potential to provide medical benefits, there is an important threshold question: what would the human health impacts be of using these substances over a long period of time? Even if they are medically valuable in the short term, might there be long-term consequences of concern?

We have been working to answer these questions with a team of researchers at the McLean Hospital, a teaching hospital of The Harvard Medical School. With funding from Heffter, they are studying the effects of peyote use in members of The Native American Church. In their religious services, church members legally consume peyote, which contains the potent hallucinogen mescaline. They often consume large quantities over a period of many years. Thus they offer an excellent test case for studying the health effects of long-term hallucinogen use.

The point of the study is to measure, with a variety of sensitive techniques, what effects the long-term-peyote use may have had. The initial results suggest that there are no cognitive deficits, nor any physical or psychological problems from church members? use of peyote. If this is the ultimate finding, it will be an important foundation for the medical use of hallucinogens.



Addiction Treatment: Heroin

Heffter has for several years been working with and funding a group of addiction researchers in Russia, at The St. Petersburg Center of Addictions, led by Dr. Evgeny Krupitsky. They have done excellent studies on the use of hallucinogen-assisted psychotherapy in the treatment of alcohol addiction. Last year, they completed a study of hallucinogen-assisted psychotherapy for the treatment of heroin addiction. Patients who received a single session of this treatment showed remarkable improvement: approximately 70% were abstinent two months after the session. So it appears that hallucinogen-assisted psychotherapy provides temporary but effective anti-addictive benefits for a period of time lasting one or two months. This new project looks into how to extend these befits for longer periods of time.

Repeated dosing at the appropriate intervals may give an addict a sustainable, steady improvement in overall adjustment and level of functioning. With funding from Heffter, this multiple dose study is now underway. A three-year effort, it should produce valuable initial results this year.



Conclusion

This is shaping up to be an important year for the Institute. I look forward to sharing news of our findings with you, ones that will lead to a deeper understanding of how the mind works, and improve the lot of people who are suffering from a variety of medical conditions.








:smirk:


--------------------
http://heffter.org

Extras: Filter Print Post Top
OfflinemotamanM
old hand
 User Gallery
Registered: 12/18/02
Posts: 6,047
Last seen: 7 days, 13 hours
Re: Dennis McKenna [Re: motaman]
    #3787686 - 02/16/05 01:26 AM (19 years, 1 month ago)

Quote:

Dr. Dennis J. McKenna
Co-founder, Director of Ethnopharmacology.



For the last twenty-five years, Dennis McKenna has pursued the interdisciplinary study of ethnopharmacology and plant hallucinogens. He is co-author, with his brother Terence, of The Invisible Landscape: Mind, Hallucinogens, and the I Ching (Seabury Press, 1975; Citadel Press, 1991), a philosophical and metaphysical exploration of the ontological implications of psychedelic drugs which resulted from the two brothers' early investigations of Amazonian hallucinogens in 1971. He received his doctorate in 1984 from the University of British Columbia. His doctoral research focused on ethnopharmacological investigations of the botany, chemistry, and pharmacology of ayahuasca and oo-koo-he, two orally-active tryptamine-based hallucinogens used by indigenous peoples in the Northwest Amazon. Following the completion of his doctorate, Dr. McKenna received post-doctoral research fellowships in the Laboratory of Clinical Pharmacology, National Institute of Mental Health, and in the Department of Neurology, Stanford University School of Medicine. In 1990, he joined Shaman Pharmaceuticals as Director of Ethnopharmacology. He relocated to Minnesota in 1993 to join the Aveda Corporation, a manufacturer of natural cosmetic products, as Senior Research Pharmacognosist. He currently works as a scientific consultant to clients in the herbal, nutritional, and pharmaceutical industries. Together with two colleagues in the natural products industry, he incorporated the non-profit Institute for Natural Products Research (INPR) in October 1998 to promote research and scientific education with respect to botanical medicines and other natural medicines. Dr. Mckenna serves on the Advisory Board of the American Botanical Council, and on the Editorial Board of Phytomedicine, International Journal of Phytotherapy and Phytopharmacology. He is a founding board member and Vice-President of the Heffter Research Institute, a non-profit scientific organization dedicated to the investigation of therapeutic applications for psychedelic plants and compounds. He has also served as board member and Research Advisor to Botanical Dimensions, a non-profit organization dedicated to the investigation of ethnomedically significant plants. He was a primary organizer and key scientific collaborator for the Hoasca Project, an international biomedical study of Hoasca, a psychoactive drink used in ritual contexts by indigenous peoples and syncretic religious groups in Brasil. He has conducted extensive ethnobotanical fieldwork in the Peruvian, Colombian, and Brasilian Amazon. He has served as invited speaker at numerous scientific congresses, seminars, and symposia. Dr. McKenna is author or co-author of over 35 scientific papers in peer-reviewed journals. His publications have appeared in the Journal of Ethnopharmacology, European Journal of Pharmacology, Brain Research, Journal of Neuroscience, Journal of Neurochemistry, Journal of Nervous and Mental Disease, Economic Botany, and elsewhere.


Publications

Lebot, Vincent, Ed Johnston, Qun Yi Zheng, Doug McKern, and Dennis J. McKenna (1999) Morphological, Phytochemical, and Genetic Variation in Hawaiian Cultivars of ?Awa (Kava, Piper methysticum Forster F., Piperaceae). Economic Botany 53:407-418.

Callaway, J. C., D. J. McKenna, C. S. Grob, G. S. Brito, L. P. Raymon, R.E. Poland, E. N. Andrade, E. O. Andrade, D. C. Mash (1999) Pharmacokinetics of Hoasca alkaloids in Healthy Humans. Journal of Ethnopharmacology. 65:243-256.

Callaway, J. C, D. J. McKenna (1998) Neurochemistry of psychedelic drugs. In Koch, S. (ed.) Handbook of Drug Abuse, CRC Press, Boca Raton, FL.

Callaway, J. C., L. P. Raymon, W. L. Hearn, D. J. McKenna, C. S. Grob, G. S. Brito, D. C. Mash (1996) Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with Ayahuasca. Journal of Analytical Toxicology 20: 492-497

Dennis J. McKenna (1996) Plant hallucinogens: Springboards for psychotherapeutic drug discovery. Behavioural Brain Research 73:109-116

C. S. Grob, D. J. McKenna, J. C. Callaway, G. S. Brito, E. S. Neves, G. Oberlender, O. L. Saide, E. Labigalini, C. Tacla, C. T. Miranda, R. J. Strassman, K. B. Boone (1996) Human pharmacology of hoasca, a plant hallucinogen used in ritual context in Brasil: Journal of Nervous & Mental Disease. 184:86-94.

James C. Callaway, M. M. Airaksinen, Dennis J. McKenna, Glacus S. Brito, & charles S. Grob (1994) Platelet serotonin uptake sites increased in drinkers of ayahuasca. Psychopharmacology 116: 385-387

Dennis J. McKenna, L. E. Luna, & G. H. N. Towers, (1995) Biodynamic constituents in Ayahuasca admixture plants: an uninvestigated folk pharmacopoeia. In: von Reis, S., and R. E. Schultes (eds). Ethnobotany: Evolution of a Discipline. Dioscorides Press, Portland

Constantino M. Torres, David B. Repke, Kelvin Chan, Dennis McKenna, Augustin Llagostera, and Richard E. Schultes (1992) Botanical, chemical, and contextual analysis of archaeological snuff powders from San Pedro de Atacama, Northern Chile. Current Anthropology. 32:640-649.

Chester A. Mathis, John M. Gerdes, Joel D. Enas, John M. Whitney, Scott E. Taylor, Yi Zhang, Dennis J. McKenna, Sona Havlik, and Stephen J. Peroutka (1992) Binding potency of paroxetine analogues for the serotonin uptake complex. Journal of Pharmacy and Pharmacology. 44:801-805.

Dennis J. McKenna, X.-M. Guan, and A. T. Shulgin (1991) 3,4-methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine. Pharmacology, Biochemistry, and Behavior. 38:505-512.

Constantino M. Torres, David B. Repke, Kelvin Chan, Dennis McKenna, Augustin Llagostera, and Richard E. Schultes (1992) Botanical, chemical, and contextual analysis of archaeological snuff powders from San Pedro de Atacama, Northern Chile. Current Anthropology. 32:640-649.

Chester A. Mathis, John M. Gerdes, Joel D. Enas, John M. Whitney, Scott E. Taylor, Yi Zhang, Dennis J. McKenna, Sona Havlik, and Stephen J. Peroutka (1992) Binding potency of paroxetine analogues for the serotonin uptake complex. Journal of Pharmacy and Pharmacology. 44:801-805.

David E. Nichols, Robert Oberlender, and Dennis J. McKenna (1991) Stereochemical Aspects of Hallucinogenesis. Chapter 1, pp. 1-39 in R. R. Watson (ed.) Biochemistry and Physiology of Substance Abuse, Vol. III. CRC Press, Boca Raton, FL.

Dennis J. McKenna and Stephen J. Peroutka (1990) Serotonin neurotoxins: Focus on MDMA (3,4-methylenedioxymethamphetamine, "Ecstasy") In S. J. Peroutka, (ed.) Serotonin Receptor Subtypes: Basic and Clinical Aspects, Alan R. Liss Publishers, New York. pp. 127-148.

Dennis J. McKenna, David B. Repke, Leland Lo, and Stephen J. Peroutka (1990) Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes. Neuropharmacology. 29:193-198.

Dennis J. McKenna and Stephen J. Peroutka (1990) The neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy"). J. Neurochemistry. 54:14-22.

Cameron R. Hekmatpanah, Dennis J. McKenna, and Stephen J. Peroutka (1989) Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity. Neuroscience Letters. 104:178-182.

Dennis J. McKenna, David B. Repke, and Stephen J. Peroutka (1989) Hallucinogenic indolealkylamines are selective for 5HT2A binding sites. Neuroscience Abstracts. 15:485.

Dennis J. McKenna & Stephen J. Peroutka (1989) Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)?2,5,-dimethoxyphenylisopropylamine (125I-R(?)DOI) and 3H-ketanserin. J. of Neuroscience. 9:3482-3490.

Dennis J. McKenna, Adil J. Nazarali, Andrew J. Hoffman, David E. Nichols, C. A. Mathis, & Juan M. Saavedra (1989) Common receptors for hallucinogens in rat brain: a comparative autoradiographic study using [125I]LSD and [125I]-DOI, a new psychotomimetic radioligand. Brain Res. 476:45-56.

Dennis J. McKenna, Adil J. Nazarali, Akihiko Himeno, & Juan M. Saavedra (1989) Chronic treatment with (?)DOI, a psychotomimetic 5HT2 agonist, downregulates 5HT2 receptors in rat brain. Neuropsychopharmacology, 2:81-87.

Adil J. Nazarali, Dennis J. McKenna, & Juan M. Saavedra (1989) Autoradiographic localization of 5HT2 receptors in rat brain using [125I]-DOI, a selective psychotomimetic radioligand. Prog. Neuropsychopharmacol. and Biol. Psychiatry, 13:573-581

Dennis J. McKenna, C. A. Mathis, & Stephen J. Peroutka (1988) Characterization of 125I-DOI binding sites in rat brain. Neuroscience Abstracts 14:No. 247.12 Akihiko Himeno, Dennis J. McKenna, Adil J. Nazarali, & Juan M. Saavedra (1988) (?)DOI, a hallucinogenic phenylalkylamine, downregulates 5HT2 receptors in rat brain. Neuroscience Abstracts 14:No. 229.2

Dennis J. McKenna & J. M. Saavedra (1987) Autoradiography of LSD and 2,5-dimethoxyphenylisopropylamine psychotomimetics demonstrates regional, specific cross-displacement in the rat brain. Eur. J. Pharmacol. 142:313-315.

Dennis J. McKenna, C. A. Mathis, A. T. Shulgin, & J. M. Saavedra (1987) Hallucinogens bind to common receptors in the rat forebrain: a comparative study using 125I-LSD and 125I-DOI, a new psychotomimetic radioligand. Neuroscience Abstracts, 13:No. 311.14

Dennis J. McKenna, C. A. Mathis, A. T. Shulgin, Thornton Sargent III, & J. M. Saavedra (1987) Autoradiographic localization of binding sites for 125I-(?)DOI, a new psychotomimetic radioligand, in the rat brain. Eur J. Pharmacol., 137:289-290.

Dennis J. McKenna, L. E. Luna, & G. H. N. Towers, (1986) Biodynamic constituents in Ayahuasca admixture plants: an uninvestigated folk pharmacopoeia. America Indigena, 46:73-101. (Spanish with English abstract)

Dennis J. McKenna, & G. H. N. Towers, (1985) On the comparative ethnopharmacology of the Malpighiaceous and Myristicaceous hallucinogens. J. Psychoactive Drugs, 17:35-39.

Dennis J. McKenna, & G. H. N. Towers, (1984), Biochemistry and pharmacology of tryptamine and ?-carboline derivatives: A minireview. J. Psychoactive Drugs, 16:347-358.

Dennis J. McKenna, G. H. N. Towers, & F. S. Abbott (1984) Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and ?-carboline constituents of Ayahuasca. J. of Ethnopharmacology 10:195-223.

Dennis J. McKenna, G. H. N. Towers, & F. S. Abbott (1984) Monoamine oxidase inhibitors in South American hallucinogenic plants Pt. II: Constituents of orally active Myristicaceous hallucinogens. J. of Ethnopharmacology 12:179-211.

Dennis J. McKenna & G. H. N. Towers (1981) Ultra-violet mediated cytotoxic activity of ?-carboline alkaloids. Phytochemistry 20:1001-1004

Dennis J. McKenna & T. K. McKenna (1975) The Invisible Landscape. Seabury Press, New York.
Book Reviews & Popular Articles

Dennis J. McKenna (1989) Its a Jungle Out There: Biochemical Conflict and Co-operation in the Ecosphere. Whole Earth Review, 64:40-47. (popular article on chemical ecology)

Dennis J. McKenna (1989) Plant Wisdom Resources. Whole Earth Review, 64:48-49.

Dennis J. McKenna (1992) DMT: Nature's Ubiquitous Hallucinogen. Interdependances, in press.

Dennis J. McKenna (1992) Tryptamine Hallucinogens of the New World: An Ethnopharmacological Survey. Interdependances, in press.

Review: The Healing Forest: Medicinal & Toxic Plants of the Northwest Amazonia by R. E. Schultes & R.F. Raffauf. Reviewed in Shaman's Drum, Spring, 1991 and Whole Earth Review, Spring, 1991

Review: The Sacred Mushroom Seeker: Essays for R. Gordon Wasson Thomas J. Reidlinger, Editor. Reviewed in Shaman's Drum, Winter 1990-91 and Whole Earth Review, Spring, 1991

Review: Ayahuasca Visions: The Religious Iconography of a Peruvian Shaman, by Luis Eduardo Luna & Pablo Amaringo. Reviewed in Shaman's Drum, Spring, 1992

Review: PIHKAL: A Chemical Love Story, by Alexander T. Shulgin & Ann Shulgin. Reviewed in Gnosis, Spring, 1992







--------------------
http://heffter.org

Extras: Filter Print Post Top
OfflineVertigo6911
Entheobotanist
Male User Gallery

Folding@home Statistics
Registered: 12/04/04
Posts: 1,834
Loc: Netherlands
Last seen: 17 years, 4 months
Re: Dennis McKenna [Re: motaman]
    #3791671 - 02/17/05 02:42 AM (19 years, 1 month ago)



--------------------
-Know ye not that ye are gods?-
My homepage

Extras: Filter Print Post Top
Offlinelonebuddha
whats it allabout?
Registered: 11/01/04
Posts: 255
Last seen: 3 years, 9 months
Re: Dennis McKenna [Re: motaman]
    #3795734 - 02/17/05 09:24 PM (19 years, 1 month ago)

Wow, thanks for the enlightenment

Extras: Filter Print Post Top
OfflineVertigo6911
Entheobotanist
Male User Gallery

Folding@home Statistics
Registered: 12/04/04
Posts: 1,834
Loc: Netherlands
Last seen: 17 years, 4 months
Re: Dennis McKenna [Re: lonebuddha]
    #3797157 - 02/18/05 03:48 AM (19 years, 1 month ago)

i have another question:
how does dennis feel about ayahuasca being readily available
over the net after coming so close to being lost?...
how does the commercial product compare to the original?


--------------------
-Know ye not that ye are gods?-
My homepage

Extras: Filter Print Post Top
InvisibleCJay
Dark Stranger
 User Gallery

Registered: 02/02/04
Posts: 931
Loc: Riding a bassline
Re: Dennis McKenna [Re: motaman]
    #3797569 - 02/18/05 08:29 AM (19 years, 1 month ago)

Quote:

will be audio interviewing Dr. Dennis McKenna in a couple of weeks which will be aired on ShroomeRadio.



kool!

Make sure you advertise the show loud and proud....this should be good

:cool:

Extras: Filter Print Post Top
Offlinetomas
half scientist,half monkey

Registered: 01/31/05
Posts: 45
Last seen: 18 years, 6 months
Re: Dennis McKenna [Re: CJay]
    #3798903 - 02/18/05 02:35 PM (19 years, 1 month ago)

Thanks to the efforts of the Heffter Research Institute and MAPS, among others, research on psychedelics is now back. What can we (the underground community) do to help, and how can we get involved in the academic world, other than as subjects?

Extras: Filter Print Post Top
OfflinemotamanM
old hand
 User Gallery
Registered: 12/18/02
Posts: 6,047
Last seen: 7 days, 13 hours
Re: Dennis McKenna [Re: tomas]
    #3848207 - 02/28/05 05:46 PM (19 years, 1 month ago)

^


--------------------
http://heffter.org

Extras: Filter Print Post Top
OfflineLearyfanS
It's the psychedelic movement!
Male User Gallery

Registered: 04/20/01
Posts: 34,184
Loc: High pride!
Last seen: 8 hours, 1 minute
Re: Dennis McKenna [Re: Rose]
    #3848661 - 02/28/05 07:15 PM (19 years, 1 month ago)

Quote:

Cervantes said:
Leary's Merry "Prankster-type" approach can sound a bit antique to THIS generation.




Did you mean Kesey?

I would like to simply ask Dennis what he likes about The Shroomery. It would be cool if you said the name of the poster ask these question as well.






--------------------
--------------------------------


Mp3 of the month:  Sons Of Adam - Feathered Fish


Extras: Filter Print Post Top
Invisiblephalloidin

Registered: 07/03/04
Posts: 865
Re: Dennis McKenna [Re: Learyfan]
    #3850434 - 03/01/05 02:22 AM (19 years, 1 month ago)

I'd like to hear his account of the events at La Chorrera and its aftermath.

Extras: Filter Print Post Top
Jump to top Pages: 1 | 2 | Next >  [ show all ]

Shop: Kraken Kratom Kratom Capsules for Sale   MagicBag.co All-In-One Bags That Don't Suck   North Spore Bulk Substrate   Mushroom-Hut Mono Tub Substrate   Left Coast Kratom Buy Kratom Extract   PhytoExtractum Buy Bali Kratom Powder   Unfolding Nature Unfolding Nature: Being in the Implicate Order


Similar ThreadsPosterViewsRepliesLast post
* Psychedelic Adventures at the Edge of the Abyss: The Ideas of Terence and Dennis McKenna
( 1 2 3 4 5 all )
YthanA 7,505 96 06/06/11 02:14 PM
by timelapses
* The Motaman Monthly One-on-One World Spirit 1,527 13 06/16/03 04:33 PM
by Azmodeus
* radio
( 1 2 all )
Anonymous 2,420 26 01/17/05 09:04 PM
by World Spirit
* On the mjshroomer situation. . .
( 1 2 3 4 all )
idiotek 9,521 68 08/13/07 11:13 AM
by Anno
* In Regardes to 1d10+3k's comments in the mjshroomer situation.
( 1 2 3 all )
meat_master_king 3,117 44 10/11/12 09:36 AM
by Alan Rockefeller
* done but with errors on page backupwards 1,251 3 02/10/06 12:42 AM
by Ythan
* Having problems veiwing site with Mozilla Firefox Lana 3,538 11 10/07/04 12:55 PM
by Lana
* Question about ratings system.
( 1 2 3 all )
Anonymous 8,870 46 12/08/04 09:29 PM
by geokills

Extra information
You cannot start new topics / You cannot reply to topics
HTML is disabled / BBCode is enabled
Moderator: Ythan, Thor, Seuss, geokills
3,334 topic views. 0 members, 0 guests and 10 web crawlers are browsing this forum.
[ Show Images Only | Sort by Score | Print Topic ]
Search this thread:

Copyright 1997-2024 Mind Media. Some rights reserved.

Generated in 0.026 seconds spending 0.005 seconds on 14 queries.